An official website of the United States government
Home
Name
CYNK-001
Alternate Names
None
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
None
NSC Number
None
Primary Site
Brain
Histology
Glioblastoma multiforme
Remarks
March 19, 2021 CYNK-001, a natural killer cell therapy, has received Fast Track designation from FDA for the treatment of adults with recurrent glioblastoma multiforme.
Coding
This drug should be coded
